Alnylam Pharmaceuticals | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Social & Marketing
Development
Video & Media
Email & Communication
Keywords & Focus Areas
Alnylam Pharmaceuticals
Overview
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, specializing in the discovery, development, and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. Founded in 2002, the company has established itself as a leader in RNAi technology, grounded in Nobel Prize-winning research in gene silencing and supported by a robust pipeline and five approved RNAi therapeutics.
The company develops medicines targeting rare and common conditions, with approved drugs for transthyretin amyloidosis, acute hepatic porphyria, primary hyperoxaluria, and hypercholesterolemia. Alnylam advances investigational candidates for conditions such as gout and Alzheimerβs, while collaborating with major pharmaceutical and biotech firms to further its mission of transforming RNAi science into effective medicines.
Basic Information
| Industry | research |
|---|---|
| Founded | 2002 |
| Revenue | $3.7B |
| Headquarters | 675 W Kendall St, Cambridge, Massachusetts 02142-1168, United States |
| Languages | English |
Contact Details
- Phone: +1 617-551-8200
- Website: alnylam.com
- LinkedIn: linkedin.com/company/alnylam-pharmaceuticals
Key Focus Areas & Initiatives
- Discovery and development of RNA interference (RNAi) therapeutics
- Gene silencing research and technology
- Drug development for rare and common genetic diseases
- Commercialization of approved RNAi medicines
- Therapeutic pipeline for cardiovascular, metabolic, and neurological diseases
- Clinical trials and investigator-initiated studies
- Patient advocacy and access philosophy
- Collaboration with pharmaceutical and biotech partners
- Diversity, equity, and inclusion initiatives
- Corporate responsibility and sustainability efforts
- Genetic testing and precision medicine innovation
Technologies Used
- ABB Distributed Control Systems (DCS)
- AI
- AVImark Rapport
- Amazon AWS
- Amazon SES
- Amazon Virtual Private Cloud (Amazon VPC)
- Analyzer
- Android
- BASE
- Batch
- Bootstrap Framework
- Cisco Prime Infrastructure
- Drupal
- Electron
- Excel4Apps
- Facebook Custom Audiences
- Facebook Login (Connect)
- Facebook Widget
- Flow
- Gem
- Google Analytics
- Google Font API
- Google Maps
- Google Maps (Non Paid Users)
- Google Tag Manager
- HPLC
- Homestead
- Hotjar
- IQMS
- Intel Nios
- IoT
- Ironclad
- Jira
- LabWare LIMS
- Linkedin Marketing Solutions
- Micro
- Microsoft Excel
- Microsoft PowerPoint
- Microsoft Project
- Microsoft Word
- Mimecast
- Mobile Friendly
- New Relic
- Nginx
- Olo
- OnCore CTMS
- OneTrust
- Outlook
- Pantheon
- PyTorch
- Python
- Rackspace MailGun
- Rapid7 InsightVM
- Remote
- SAP Ariba Platform
- SAP Predictive Analytics
- SAS Enterprise Guide
- SAS/Graph
- SS&C
- Salesforce
- Salesforce CRM Analytics
- Salesforce Live Agent
- Siemens Syngo Imaging
- Slack
- Spiceworks IP Scanner
- TIBCO Spotfire
- Taleo
- Varnish
- Veeva Systems
- Vimeo
- Wagtail CMS
- Wider Planet
- WordPress.org
- YouTube
- Zoomdata
- empow